| Trial ID: | L6343 |
| Source ID: | NCT00562133
|
| Associated Drug: |
Insulin Glulisine
|
| Title: |
Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Insulin Glulisine|DRUG: Insulin
|
| Outcome Measures: |
Primary: the postprandial time course of nitrotyrosine after injection of insulin glulisine compared with regular human insulin, 1 day | Secondary: postprandial time course of blood glucose, insulin, intact proinsulin, ADMA, MMP-9, FFA, ox-LDL, per ox Status, IL-18, postprandial time course of microvascular blood circulation measured with laserdopplerflux at 37 °C and 44 C, 1 day
|
| Sponsor/Collaborators: |
Sponsor: IKFE Institute for Clinical Research and Development
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
15
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-12
|
| Completion Date: |
2007-03
|
| Results First Posted: |
|
| Last Update Posted: |
2007-11-21
|
| Locations: |
Ikfe, Mainz, Rhineland-Palatinate, 55116, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00562133
|
